Correlation Between GlaxoSmithKline PLC and Ashmore Emerging
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Ashmore Emerging at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Ashmore Emerging into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Ashmore Emerging Markets, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Ashmore Emerging and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Ashmore Emerging. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Ashmore Emerging.
Diversification Opportunities for GlaxoSmithKline PLC and Ashmore Emerging
0.52 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between GlaxoSmithKline and Ashmore is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Ashmore Emerging Markets in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ashmore Emerging Markets and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Ashmore Emerging. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ashmore Emerging Markets has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Ashmore Emerging go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Ashmore Emerging
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Ashmore Emerging. In addition to that, GlaxoSmithKline PLC is 2.41 times more volatile than Ashmore Emerging Markets. It trades about -0.28 of its total potential returns per unit of risk. Ashmore Emerging Markets is currently generating about -0.34 per unit of volatility. If you would invest 1,399 in Ashmore Emerging Markets on August 26, 2024 and sell it today you would lose (60.00) from holding Ashmore Emerging Markets or give up 4.29% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Ashmore Emerging Markets
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| Ashmore Emerging Markets |
GlaxoSmithKline PLC and Ashmore Emerging Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and Ashmore Emerging
The main advantage of trading using opposite GlaxoSmithKline PLC and Ashmore Emerging positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Ashmore Emerging can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ashmore Emerging will offset losses from the drop in Ashmore Emerging's long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| Ashmore Emerging vs. Hennessy Bp Energy | Ashmore Emerging vs. Clearbridge Energy Mlp | Ashmore Emerging vs. Dreyfus Natural Resources | Ashmore Emerging vs. Alpsalerian Energy Infrastructure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |